Miami, FLNCT07168993Now EnrollingIRB Ready

Lung Cancer (Diagnosis) Clinical Trial in Miami, FL

Access cutting-edge lung cancer (diagnosis) treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by bioAffinity Technologies Inc.

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions…

Expert Care in Miami

Access lung cancer (diagnosis) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lung cancer (diagnosis) treatment provided free

Apply for This Miami Location

Check if you qualify for this lung cancer (diagnosis) clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Lung Cancer (Diagnosis) Study in Miami

Evaluate FlowPath Lung Diagnostic Test of Sputum Samples to Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, \>6 to \<30 mm in Diameter, Determined by LDCT.

Sponsor: bioAffinity Technologies Inc.

Who Can Participate

Inclusion Criteria

Is able to give signed informed consent and comply with study requirements.
Is high risk for getting lung cancer:
≥50 - 80 years of age.
current smoker with smoking history of at least 20 pack-years or current non-smoker with smoking history of at least 20 pack-years who quit smoking within the past 15 years.
Has a \>6 to \<30 mm diameter lung nodule (found by lung cancer screening or found incidentally by CT scan) as determined by CT and is willing to provide a sputum sample for FlowPath Lung test within 6 weeks of the prestudy baseline CT scan. 3a) Nodule is either new, increasing, or stable for ≤ 6 months. 3b) In cases where a person has multiple nodules as determined by CT scan, the subject's most suspicious nodule is \>6 to \<30 mm in diameter. 4\) Is willing to provide contact information to the study PI or the treating physician(s) who can release required medical information related to SOC follow-up.

Exclusion Criteria

Is unable to cough with sufficient exertion to produce a sputum sample (e.g., due to severe obstructive lung disease).
The dominant nodule is ground glass or part solid as determined by CT scan.
Has 5 or more nodules sized \>4 mm.
The nodule sized \>6 to \<30 mm in diameter is a distal (subsegmental) endobronchial nodule or a perifissural nodule.
Is immunosuppressed.
Has rheumatoid arthritis.
Had lung cancer diagnosis in the past 5 years or any other cancer (other than non-melanoma skin cancer) in the past 2 years. A subject on long-term medications used for prevention of cancer, such as Tamoxifen for breast cancer, is not excluded.
Has angina with minimal exertion.
Is currently pregnant or planning on becoming pregnant during this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT07168993) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lung Cancer (Diagnosis) Treatment Options in Miami, FL

If you're searching for lung cancer (diagnosis) treatment options in Miami, FL, this clinical trial (NCT07168993) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer (diagnosis) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lung cancer (diagnosis) clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Miami, FL

See all lung cancer clinical trials recruiting in Miami — not just this study.

Browse Lung Cancer Trials in Miami →

Browse More Trials by Condition

Lung Cancer TrialsAll Conditions →

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL